BOSTON, Oct. 10, 2019 /PRNewswire/ -- Increasing prevalence of chronic disease, rapidly aging populations, and huge middle-class growth in developing economies are combining to push the growth in global healthcare expenditure from 2.4% in 2015 to an estimated 7.5% by 2020, making next year's growth alone an additional $750 billion. For many

VENICE, Fla., Oct. 10, 2019 /PRNewswire/ -- Tuscan Gardens® of Venetia Bay has partnered with Seattle-based Elde

CARLSBAD, Calif., Oct. 10, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that its scientists will present data highlighting advances in the company's antisense technology that have the potential to address an unprecedented range of diseases at the 15th Annual Meeting of the Oligon

DAVIS, Calif., Oct. 10, 2019 /PRNewswire/ -- EicOsis LLC, a pharmaceutical startup developing a new class of oral non-narcotic analgesics, announced today that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate Phase 1 clinical trials for their drug candidate, EC5026, for the treatment of pain.

SANTA CLARA, Calif., Oct. 10, 2019 /PRNewswire/ -- Glassbeam, Inc., the premier machine data analytics company, announced today that it has expanded its strategic reseller relationship with Agiliti Imaging ("Agiliti"), a division of Agiliti, Inc., more than doubling its current installed base in the Southern California region. Glassbeam s

REDWOOD CITY, Calif., Oct. 10, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its financial results for the third quarter ended September 30, 2019 after the market closes on

SAN FRANCISCO, Oct. 10, 2019 /PRNewswire/ -- Lawsuit Settlement News reports that over 13,000 plaintiffs have filed suit against Monsanto (a subsidiary of Bayer) due to alleged toxic exposure to the manufacturer's Roundup brand weed killer. Plaintiffs claim their non-Hodgkin lymphoma was directly caused by exposure to the glyphosate-based product. Four plaintiffs

MONMOUTH JUNCTION, N.J., Oct. 10, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its

SMITHS FALLS, ON, Oct. 10, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to announce that David Klein has been appointed Chair of its Board of Directors effective immediately.

SAN FRANCISCO, Oct. 10, 2019 /PRNewswire/ -- EPIC Insurance Brokers & Consultants (Edgewood Partners Insurance Center or EPIC), a retail property and casualty insurance brokerage and employee benefits consultant, announced today the expansion and reorganization of its healthcare practice.